Cargando…
Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria
Malaria afflicts around 200 million people annually, with a mortality number close to 600,000. The mortality rate in Human Cerebral Malaria (HCM) is unacceptably high (15–20%), despite the availability of artemisinin-based therapy. An effective adjunct therapy is urgently needed. Experimental Cerebr...
Autores principales: | Dende, Chaitanya, Meena, Jairam, Nagarajan, Perumal, Panda, Amulya K., Rangarajan, Pundi N., Padmanaban, Govindarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521148/ https://www.ncbi.nlm.nih.gov/pubmed/26227888 http://dx.doi.org/10.1038/srep12671 |
Ejemplares similares
-
Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria
por: Dende, Chaitanya, et al.
Publicado: (2017) -
Curcumin-Arteether Combination Therapy of Plasmodium berghei-Infected Mice Prevents Recrudescence Through Immunomodulation
por: Vathsala, Palakkod G., et al.
Publicado: (2012) -
Malaria parasite heme biosynthesis promotes and griseofulvin protects against cerebral malaria in mice
por: Chandana, Manjunatha, et al.
Publicado: (2022) -
Adipose tissue parasite sequestration drives leptin production in mice and correlates with human cerebral malaria
por: Mejia, Pedro, et al.
Publicado: (2021) -
Severity of Retinopathy Parallels the Degree of Parasite Sequestration in the Eyes and Brains of Malawian Children With Fatal Cerebral Malaria
por: Barrera, Valentina, et al.
Publicado: (2015)